Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Phase 3

Recruiting

Conditions: Brain Metastases

Interventions: Procedure: Stereotactic Radiosurgery (SRS)
Drug: Memantine
Radiation: Hippocampal-avoidant (HA-WBRT) Radiotherapy

First Posted Date: 2018-06-08

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 206

Registration Number: NCT03550391

Locations: 🇺🇸
University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
🇺🇸
University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
🇺🇸
City of Hope Corona, Corona, California, United States

and more 83 locations

(D)Elayed vs. (E)Arly (L)Aparoscopic (A)Ppendectom(Y)

Not Applicable

Completed

Conditions: Appendicitis

Interventions: Procedure: Appendectomy

First Posted Date: 2018-05-15

Last Posted Date: 2023-11-18

Lead Sponsor: Queen's University

Target Recruit Count: 127

Registration Number: NCT03524573

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

Prostate Vaporization Techniques in Canadian Hospital

Not Applicable

Completed

Conditions: Direct Costs Excluding Capital Equipment Purchase
Operator (Surgeon) Completed Questionnaire
3 Month Efficacy Evaluation (Compared to Baseline) Using Validated Symptom Assessment Tools (See Outcome Metrics for Details)
Operative Parameters (Time, Bleeding Etc)
Complications (Post-op Retention, Bleeding, Re-admission to Hospital, Infection Etc)

Interventions: Procedure: Clarion Evolve Laser Vaporization System
Procedure: Olympus TURis Plasma Vaporization

First Posted Date: 2018-04-11

Last Posted Date: 2018-04-13

Lead Sponsor: Queen's University

Target Recruit Count: 55

Registration Number: NCT03495258

Locations: 🇨🇦
Centre for Applied Urological Research, Kingston, Ontario, Canada

Remote Cognitive Remediation for Depression

Not Applicable

Conditions: Major Depression

Interventions: Behavioral: Active Cognitive Remediation
Behavioral: Cognitive Remediation Control
Behavioral: Online computer exercises
Behavioral: Strategy monitoring
Behavioral: Bridging strategies

First Posted Date: 2018-04-10

Last Posted Date: 2018-08-29

Lead Sponsor: Queen's University

Target Recruit Count: 75

Registration Number: NCT03492203

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

A Novel Treatment Approach for Self-Stigma in First Episode Psychosis

Not Applicable

Conditions: Psychotic Disorders

Interventions: Behavioral: BOOST Intervention
Behavioral: Waitlist Control

First Posted Date: 2018-04-09

Last Posted Date: 2018-08-28

Lead Sponsor: Queen's University

Target Recruit Count: 40

Registration Number: NCT03491852

Locations: 🇨🇦
St. Joseph's Healthcare Hamilton, West 5th Campus, Hamilton, Ontario, Canada

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Phase 3

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: Radiation
Other: No Radiation

First Posted Date: 2018-04-05

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 2140

Registration Number: NCT03488693

Locations: 🇺🇸
Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
🇺🇸
University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
🇺🇸
University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

and more 457 locations

Open Facet Joint Denervation in the Treatment of Low Back Pain

Not Applicable

Completed

Conditions: Back Pain

Interventions: Procedure: facet joint denervation

First Posted Date: 2018-04-03

Last Posted Date: 2023-04-10

Lead Sponsor: Queen's University

Target Recruit Count: 60

Registration Number: NCT03487120

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Phase 2

Active, not recruiting

Conditions: Ovarian Cancer Prevention

Interventions: Other: Placebo
Drug: Acetylsalicylic acid

First Posted Date: 2018-03-29

Last Posted Date: 2025-03-05

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 117

Registration Number: NCT03480776

Locations: 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Randwick, New South Wales, Australia
🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia

and more 14 locations

Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)

Phase 2

Terminated

Conditions: Advanced Solid Tumors

Interventions: Drug: Nivolumab
Drug: Ipilimumab

First Posted Date: 2018-03-12

Last Posted Date: 2024-02-22

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 4

Registration Number: NCT03461952

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

and more 3 locations

Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Tiotropium + Olodaterol
Other: PLACEBO

First Posted Date: 2018-02-07

Last Posted Date: 2019-02-05

Lead Sponsor: Queen's University

Target Recruit Count: 25

Registration Number: NCT03425617

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy